Gouty Arthritis Industry Overview 2025: Growth Projections and Market Trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Gouty Arthritis Market?

The gouty arthritis market has seen robust expansion in recent years. It is anticipated to expand from $3.44 billion in 2024 to $3.69 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. This past growth can be attributed to the widespread occurrence of chronic diseases, a rise in alcohol consumption, an expanding elderly demographic, increasing acceptance of improved regeneration therapies, and growing expenditure on healthcare.

The gouty arthritis market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $4.8 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast timeframe is attributable to several factors, including advancements in healthcare infrastructure, a rise in obesity rates, a higher occurrence of gout, and greater public awareness. Key trends expected during the forecast period encompass an increasing need for effective treatment solutions, the development of regenerative therapies, significant technological progress, new product introductions, and successful regulatory clearances.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

Which Factors And Drivers Are Influencing The Gouty Arthritis Market In 2025?

A growing incidence of obesity is anticipated to stimulate the expansion of the gouty arthritis market in the foreseeable future. This condition, obesity, is defined as a medical state marked by an excessive accumulation of body fat that jeopardizes an individual’s well-being, commonly assessed via the body mass index (BMI). The escalating obesity rate is attributed to greater intake of high-calorie, processed foods and inactive living patterns. Obesity contributes to gouty arthritis by boosting uric acid production and diminishing the body’s excretion capability, resulting in the build-up of uric acid crystals within the joints. Furthermore, surplus body weight imposes additional strain on joints, intensifying the inflammation and discomfort linked with gout. As an illustration, data from March 2022 released by the World Health Organization, a Switzerland-based specialized United Nations agency responsible for worldwide public health, indicated that approximately 1 billion individuals, including 650 million adults, 340 million teenagers, and 39 million children, were categorized as obese, with this number consistently increasing. Moreover, forecasts suggest that by 2025, around 167 million adults and children will experience adverse health effects stemming from their excess weight. Consequently, the rising occurrence of obesity is fueling the expansion of the gouty arthritis market.

What Are The Different Segment Classifications Within The Gouty Arthritis Market?

The gouty arthritismarket covered in this report is segmented –

1) By Type: Acute Gouty Arthritis; Chronic Gouty Arthritis

2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Pain Reliever; Corticosteroids; Xanthine Oxidase Inhibitors; Uricosurics; Others Treatments

3) By Diagnosis: Joint Fluid Test; Blood Test; X-Ray Imaging; Ultrasound; Dual Energy Computed Tomography (CT) Scan; Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Others Distribution Channels

5) By End-Users: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout; Acute Gout Attack (Intermittent Flares); Severe Acute Gout With Joint Deformities

2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits); Chronic Gout With Joint Damage; Chronic Gout With Renal Complications; Chronic Gout With Comorbidities (Hypertension, Diabetes)

What Key Innovation Trends Are Fueling Advancements In The Gouty Arthritis Market?

Major companies engaged in the gouty arthritis market are intensifying their initiatives to develop innovative products, such as cortrophin gel, with the goal of providing more effective and targeted therapies for managing the condition. Cortrophin gel, also known as repository corticotropin injection, is a purified form of the adrenocorticotropic hormone (ACTH). It is utilized to treat various inflammatory and autoimmune conditions, including gouty arthritis. For instance, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical company, obtained approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is intended for the adjunctive treatment of certain patients experiencing acute gouty arthritis flares. Cortrophin Gel is currently the only FDA-approved adrenocorticotropic hormone (ACTH) therapy indicated for treating appropriate patients with acute gouty arthritis flares.

Which Key Players Are Driving Competition In The Gouty Arthritis Market?

Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Which Region Is Projected To Lead The Gouty Arthritis Market During The Forecast Period?

North America was the largest region in the gouty arthritis market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gouty Arthritis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp

Browse Through More Reports Similar to the Global Gouty Arthritis Market 2025, By The Business Research Company

Arthritis Monoclonal Antibodie Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Psoriatic Arthritis Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Companion Animal Arthritis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795